Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eton Pharmaceuticals, Inc.

14.43
-0.6000-3.99%
Volume:356.94K
Turnover:5.23M
Market Cap:386.98M
PE:-82.40
High:15.33
Open:15.13
Low:14.32
Close:15.03
Loading ...

Top Growth Companies With Insider Stakes July 2025

Simply Wall St.
·
22 Jul

B.Riley Financial Remains a Buy on Eton Pharmaceuticals (ETON)

TIPRANKS
·
18 Jul

REFILE-BUZZ-U.S. STOCKS ON THE MOVE-BTCS, BrainStorm Cell, Moderna

Reuters
·
09 Jul

Craig-Hallum Remains a Buy on Eton Pharmaceuticals (ETON)

TIPRANKS
·
08 Jul

BUZZ-U.S. STOCKS ON THE MOVE-ProKidney, Eton Pharma, Datadog

Reuters
·
08 Jul

BUZZ-Eton Pharma rises after US FDA accepts application for hormone disorder drug

Reuters
·
08 Jul

BRIEF-Eton Pharmaceuticals Announces FDA Acceptance Of New Drug Application For Et-600

Reuters
·
08 Jul

Eton Pharmaceuticals Announces FDA Acceptance of NDA for ET-600 Desmopressin Oral Solution, Target Action Date Set for February 25, 2026

Reuters
·
08 Jul

Sector Update: Health Care Stocks Retreat Late Afternoon

MT Newswires Live
·
28 Jun

Eton Pharmaceuticals Joins Russell 2000 and 3000 Indexes

Reuters
·
27 Jun

Press Release: Eton Pharmaceuticals Announces Addition to Russell 2000(R) and Russell 3000(R) Indexes

Dow Jones
·
27 Jun

Eton Pharmaceuticals Inc. Replaces Crowe LLP with Grant Thornton as Independent Auditor

Reuters
·
21 Jun

Eton Pharmaceuticals Unveils Corporate Presentation Highlighting Focus on Ultra-Rare Disease Therapies and Growth Strategy

Reuters
·
20 Jun

David Krempa, Chief Business Officer, Reports Disposal of Common Shares of Eton Pharmaceuticals Inc

Reuters
·
17 Jun

Opaleye Management Inc. Reports Acquisition of Common Shares in Eton Pharmaceuticals Inc

Reuters
·
13 Jun

Eton Pharmaceuticals Inc. Conducted Virtual Annual Meeting of Stockholders

Reuters
·
11 Jun

Eton Pharmaceuticals Inc. CEO Sean Brynjelsen Reports Disposal of Common Shares

Reuters
·
06 Jun

Eton Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
29 May

Eton Pharmaceuticals Secures FDA Approval for KHINDIVI™ Oral Solution as Treatment for Pediatric Adrenal Insufficiency

Reuters
·
29 May

Eton Pharmaceuticals Price Target Raised to $26.00/Share From $24.00 by B. Riley Securities

Dow Jones
·
17 May